Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
about
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsHispidin induces autophagic and necrotic death in SGC-7901 gastric cancer cells through lysosomal membrane permeabilization by inhibiting tubulin polymerization.Novel indolyl-chalcones target stathmin to induce cancer cell death.Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivoStathmin 1 expression in plasma cell neoplasms.Paclitaxel induces Stathmin 1 phosphorylation, microtubule stability and apoptosis in acute lymphoblastic leukemia cells
P2860
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@ast
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@en
type
label
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@ast
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@en
prefLabel
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@ast
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@en
P2093
P2860
P50
P356
P1433
P1476
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells
@en
P2093
Adriana da Silva Santos Duarte
Fernando Ferreira Costa
João Agostinho Machado-Neto
Patricia Favaro
Paula de Melo Campos
Sara Teresinha Olalla Saad
P2860
P304
29573-29584
P356
10.18632/ONCOTARGET.4998
P407
P577
2015-08-24T00:00:00Z